ASL volume and innate defense in CF and COPD Airways
ASL volume and innate defense in CF and COPD Airways
批准号:
8115819
负责人:
ROBERT TARRAN
金额:
$49.75万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
ATP phosphohydrolaseAccountingAcuteAdenosineAnti-Inflammatory AgentsAnti-inflammatoryBreathingCLCA2 geneCellsCharacteristicsChronicChronic BronchitisChronic Obstructive Airway DiseaseCigaretteCystic Fibrosis Transmembrane Conductance RegulatorDefectDevelopmentDiseaseDoseEpithelialEpithelial CellsEventExhibitsExposure toFailureFrequenciesGoalsHeightHomeostasisHost DefenseHumanImpairmentInfectionInflammationInflammation MediatorsInflammatoryInflammatory ResponseInheritedIon ChannelIon TransportKnowledgeLeadMainstreamingMeasuresMechanicsMediatingMucinsMucociliary ClearanceMucous body substanceNoseNucleosidesPathway interactionsPatientsPhysiologicalPhysiological AdaptationPhysiological ProcessesPopulationPublic HealthPurine NucleosidesPurine NucleotidesRegulationResearchRespiratory Tract InfectionsSignal PathwaySignal TransductionSiteSurfaceSystemTestingTimeUp-RegulationViralVirus Diseasesabsorptionairway epitheliumairway inflammationairway remodelingairway surface liquidbasecigarette smokingcomputerized data processingcystic fibrosis airwaycytokinedensitydesigneffective therapyextracellularin vivomacrophageneutrophilnovelpathogenrespiratoryrespiratory infection virusresponseshear stresstherapy development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Mucus plugs form in the airway lumens of CF and COPD patients, raising the likelihood that ion transport
and mucin secretion have become uncoupled. We have previously shown that the height (volume) of normal
(NL) airway surface liquid (ASL) is regulated, and that dysregulation of CF airway ion transport due to a lack
of CFTR causes ASL volume depletion and cessation of mucus transport. This defect is predicted to
impair the mucus component of the innate host defense, leading to increased frequency of respiratory
infections. The underlying mechanisms of ASL regulation and the relevance to CF and COPD are unknown.
Our long term goal is to understand how ASL volume is autoregulated in normal as compared to diseased
(CF and COPD) airways under physiological conditions, and in response to acute challenges such as
cigarette smoke, inflammation and respiratory viral infections. We have previously observed that extracellular
purine nucleoside (adenosine)-dependent pathways for ASL volume autoregulation are present in normal but
not CF airways. However, when cultured with a novel system that mimics the shear stresses associated with
normal tidal breathing in vivo, CF cultures exhibit ASL volume homeostasis and maintain mucus transport
mediated by shear stress-dependent extracellular purine nucleotide (ATP) release. Superimposed on the
acute regulation of ASL volume by ATP and ADO are chronic effects of cytokines/inflammatory mediators
through regulation of ion channel density and signaling pathways. CF airways are uniquely vulnerable to viral
(RSV) infections deplete ASL volume via upregulation of extracellular ATPases causing reduction of ASL
ATP levels. Cigarette smoke exposure also inhibits CFTR and ADO-regulated ASL volume regulation. Based
on these observations, we propose that an initiating event in the development of COPD and CF is a failure of
ion transport to regulate ASL volume, resulting in the accumulation of poorly cleared mucus plaques/plugs
on airway surfaces. These plaques/plugs then act as the primary site of pathogen infections, impair
macrophage/neutrophil influx and ultimately lead to the airway remodeling that is characteristic of CF airway
disease and COPD. Elucidation of the basic mechanisms that account for the major inherited (CF) and
acquired (COPD) forms of chronic inflammatory airways disease is vital for the public health of the US
population. Such knowledge will likely lead to the development of novel, uniquely effective therapies for
these diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Peptide Fusion Inhibitors for the Treatment of COVID-19
-
批准号:10379832
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2022
-
负责人:ROBERT TARRAN
-
依托单位:
ELD607 Orai1 Antagonist Increases Bacterial Clearance from the Lung
-
批准号:10453601
-
项目类别:
-
资助金额:$98.82万
-
财政年份:2020
-
负责人:ROBERT TARRAN
-
依托单位:
ELD607 Orai1 Antagonist Increases Bacterial Clearance from the Lung
-
批准号:10404327
-
项目类别:
-
资助金额:$99.98万
-
财政年份:2020
-
负责人:ROBERT TARRAN
-
依托单位:
Do E-Cigarette Users Airways Have an Altered Lipid Content?
-
批准号:10037769
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2020
-
负责人:ROBERT TARRAN
-
依托单位:
Do E-Cigarette Users Airways Have an Altered Lipid Content?
-
批准号:10220134
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2020
-
负责人:ROBERT TARRAN
-
依托单位:
ELD607 Orai1 Antagonist Increases Bacterial Clearance from the Lung
-
批准号:10080273
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2020
-
负责人:ROBERT TARRAN
-
依托单位:
Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd
-
批准号:8904703
-
项目类别:
-
资助金额:$60.99万
-
财政年份:2013
-
负责人:ROBERT TARRAN
-
依托单位:
The Impact of Tobacco Exposure on the Lungs Innate Defense System
-
批准号:9328114
-
项目类别:
-
资助金额:$400.0万
-
财政年份:2013
-
负责人:ROBERT TARRAN
-
依托单位:
The Impact of Tobacco Exposure on the Lungs Innate Defense System
-
批准号:8582362
-
项目类别:
-
资助金额:$400.0万
-
财政年份:2013
-
负责人:ROBERT TARRAN
-
依托单位:
The Impact of Tobacco Exposure on the Lungs Innate Defense System
-
批准号:8737945
-
项目类别:
-
资助金额:$400.0万
-
财政年份:2013
-
负责人:ROBERT TARRAN
-
依托单位:
Core A: Administration and Bioanalysis Core
-
批准号:8904707
-
项目类别:
-
资助金额:$17.69万
-
财政年份:2013
-
负责人:ROBERT TARRAN
-
依托单位:
The Impact of Tobacco Exposure on the Lungs Innate Defense System
-
批准号:8916361
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2013
-
负责人:ROBERT TARRAN
-
依托单位:
SPLUNC1-Derived Peptides as ENaC Antagonists
-
批准号:8645717
-
项目类别:
-
资助金额:$35.61万
-
财政年份:2012
-
负责人:ROBERT TARRAN
-
依托单位:
SPLUNC1-Derived Peptides as ENaC Antagonists
-
批准号:8295783
-
项目类别:
-
资助金额:$36.33万
-
财政年份:2012
-
负责人:ROBERT TARRAN
-
依托单位:
SPLUNC1-Derived Peptides as ENaC Antagonists
-
批准号:8468206
-
项目类别:
-
资助金额:$34.59万
-
财政年份:2012
-
负责人:ROBERT TARRAN
-
依托单位:
ASL volume and innate defense in CF and COPD Airways
-
批准号:7231807
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2006
-
负责人:ROBERT TARRAN
-
依托单位:
Ion Transport and Mucus Clearance in CF Airways
-
批准号:7177545
-
项目类别:
-
资助金额:$20.77万
-
财政年份:2005
-
负责人:ROBERT TARRAN
-
依托单位:
Ion Transport and Mucus Clearance in CF Airways
-
批准号:7038269
-
项目类别:
-
资助金额:$21.39万
-
财政年份:2005
-
负责人:ROBERT TARRAN
-
依托单位:
Ion Transport and Mucus Clearance in CF Airways
-
批准号:6922179
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2005
-
负责人:ROBERT TARRAN
-
依托单位:
Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd
-
批准号:8595536
-
项目类别:
-
资助金额:$70.99万
-
财政年份:--
-
负责人:ROBERT TARRAN
-
依托单位:
海外基金